Kopin (NASDAQ:KOPN – Get Free Report) and BIO-key International (NASDAQ:BKYI – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.
Profitability
This table compares Kopin and BIO-key International’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kopin | -13.81% | -30.97% | -9.76% |
| BIO-key International | -70.23% | -73.33% | -43.89% |
Risk & Volatility
Kopin has a beta of 2.93, indicating that its share price is 193% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Kopin | $45.60 million | 8.89 | -$43.88 million | ($0.04) | -55.50 |
| BIO-key International | $6.32 million | 0.96 | -$4.30 million | ($1.04) | -0.54 |
BIO-key International has lower revenue, but higher earnings than Kopin. Kopin is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
31.0% of Kopin shares are held by institutional investors. Comparatively, 26.5% of BIO-key International shares are held by institutional investors. 2.8% of Kopin shares are held by company insiders. Comparatively, 3.7% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings and price targets for Kopin and BIO-key International, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kopin | 1 | 0 | 4 | 0 | 2.60 |
| BIO-key International | 1 | 0 | 0 | 0 | 1.00 |
Kopin presently has a consensus target price of $4.69, suggesting a potential upside of 111.15%. Given Kopin’s stronger consensus rating and higher possible upside, equities analysts clearly believe Kopin is more favorable than BIO-key International.
Summary
Kopin beats BIO-key International on 11 of the 14 factors compared between the two stocks.
About Kopin
Kopin Corporation, together with its subsidiaries, invents, develops, manufactures, and sells microdisplays, subassemblies, and related components for defense, enterprise, industrial, and consumer products in the United States, the Asia-Pacific, Europe, and internationally. It offers miniature active-matrix liquid crystal displays, liquid crystal on silicon displays/spatial light modulators, organic light emitting diode displays, microLED display technologies, application specific integrated circuits, backlights, and optical lenses; and head-mounted and hand-held VR products. The company’s products are used for soldier thermal weapon rifle sights, avionic fixed and rotary wing pilot helmets, armored vehicle targeting systems, and training and simulation headsets; industrial and medical headsets; 3D optical inspection systems; and consumer augmented reality and virtual reality wearable headsets systems. Kopin Corporation was incorporated in 1984 and is headquartered in Westborough, Massachusetts.
About BIO-key International
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
Receive News & Ratings for Kopin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kopin and related companies with MarketBeat.com's FREE daily email newsletter.
